Thrive Wealth Management, LLC Cybin Inc. Transaction History

Thrive Wealth Management, LLC

  • $541 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
SELL
$0.26 - $0.46 $14,222 - $25,162
-54,700 Reduced 66.14%
28,000 $7,000
Q1 2024

Apr 15, 2024
SELL
$0.3 - $0.46 $13,590 - $20,838
-45,300 Reduced 35.39%
82,700 $33,000
Q4 2023

Jan 09, 2024
BUY
$0.38 - $0.65 $28,500 - $48,750
75,000 Added 141.51%
128,000 $52,000
Q3 2023

Oct 13, 2023
BUY
$0.29 - $0.63 $15,369 - $33,390
53,000 New
53,000 $28,000

Others Institutions Holding CYBN

# of Institutions
11
Shares Held
185K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $2.07B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Thrive Wealth Management, LLC Portfolio

Follow Thrive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thrive Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email